vs
Side-by-side financial comparison of IAMGOLD CORP (IAG) and PHIBRO ANIMAL HEALTH CORP (PAHC). Click either name above to swap in a different company.
IAMGOLD CORP is the larger business by last-quarter revenue ($724.2M vs $373.9M, roughly 1.9× PHIBRO ANIMAL HEALTH CORP).
Iamgold Corporation is a Canadian company that owns and operates gold mines in Burkina Faso and Canada. Headquartered in Toronto, the company was incorporated in 1990, and went public on the Toronto Stock Exchange in 1996, with additional shares being listed on the New York Stock Exchange beginning in 2005. The company formerly owned or had stakes in the Sadiola and Yatela gold mines in Mali, the Mupane gold mine in Botswana, the Niobec niobium mine in Quebec, as well as a royalty in the Diav...
Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated ...
IAG vs PAHC — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $724.2M | $373.9M |
| Net Profit | — | $27.5M |
| Gross Margin | 35.4% | 35.5% |
| Operating Margin | — | 13.5% |
| Net Margin | — | 7.3% |
| Revenue YoY | — | 20.9% |
| Net Profit YoY | — | 762.1% |
| EPS (diluted) | — | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $373.9M | ||
| Q3 25 | — | $363.9M | ||
| Q2 25 | $724.2M | $378.7M | ||
| Q1 25 | $338.9M | $347.8M | ||
| Q4 24 | — | $309.3M | ||
| Q3 24 | — | $260.4M | ||
| Q2 24 | $465.0M | $273.2M | ||
| Q1 24 | $226.2M | $263.2M |
| Q4 25 | — | $27.5M | ||
| Q3 25 | — | $26.5M | ||
| Q2 25 | — | $17.2M | ||
| Q1 25 | — | $20.9M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $752.0K | ||
| Q1 24 | — | $8.4M |
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | 35.4% | 29.0% | ||
| Q1 25 | 31.2% | 30.1% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | 15.0% | 31.9% | ||
| Q1 24 | 19.1% | 30.2% |
| Q4 25 | — | 13.5% | ||
| Q3 25 | — | 14.1% | ||
| Q2 25 | — | 8.9% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 8.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 6.7% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 7.3% | ||
| Q3 25 | — | 7.3% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | $0.67 | ||
| Q3 25 | — | $0.65 | ||
| Q2 25 | — | $0.43 | ||
| Q1 25 | — | $0.51 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.17 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $74.5M |
| Total DebtLower is stronger | — | $624.2M |
| Stockholders' EquityBook value | — | $332.4M |
| Total Assets | — | $1.4B |
| Debt / EquityLower = less leverage | — | 1.88× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $74.5M | ||
| Q3 25 | — | $85.3M | ||
| Q2 25 | — | $77.0M | ||
| Q1 25 | — | $70.4M | ||
| Q4 24 | — | $67.1M | ||
| Q3 24 | — | $89.8M | ||
| Q2 24 | — | $114.6M | ||
| Q1 24 | — | $98.7M |
| Q4 25 | — | $624.2M | ||
| Q3 25 | — | $628.0M | ||
| Q2 25 | — | $631.7M | ||
| Q1 25 | — | $635.4M | ||
| Q4 24 | — | $639.1M | ||
| Q3 24 | — | $295.2M | ||
| Q2 24 | — | $312.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | $332.4M | ||
| Q3 25 | — | $311.7M | ||
| Q2 25 | — | $285.7M | ||
| Q1 25 | — | $266.0M | ||
| Q4 24 | — | $246.8M | ||
| Q3 24 | — | $258.5M | ||
| Q2 24 | — | $256.6M | ||
| Q1 24 | — | $270.1M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $966.3M | ||
| Q2 24 | — | $982.2M | ||
| Q1 24 | — | $979.0M |
| Q4 25 | — | 1.88× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 2.59× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $19.4M |
| Free Cash FlowOCF − Capex | — | $8.3M |
| FCF MarginFCF / Revenue | — | 2.2% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $47.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $19.4M | ||
| Q3 25 | — | $9.3M | ||
| Q2 25 | — | $21.3M | ||
| Q1 25 | — | $43.2M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $12.6M | ||
| Q2 24 | — | $28.4M | ||
| Q1 24 | — | $11.4M |
| Q4 25 | — | $8.3M | ||
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $35.4M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | -1.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 2.07× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.81× | ||
| Q2 24 | — | 37.80× | ||
| Q1 24 | — | 1.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IAG
Segment breakdown not available.
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
